Related Experiment Videos

Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia

Ji Li1, Ildiko Sarosi, Russell C Cattley

  • 1Department of Metabolic Disorders, Amgen Inc., Thousand Oaks, CA, USA.

Bone
|May 30, 2006
PubMed

Insights

Dickkopf-1 (Dkk1), a Wnt signaling inhibitor, directly impacts bone formation. Overexpression of Dkk1 in mice leads to osteopenia by reducing osteoblast numbers and activity, highlighting Dkk1

Area of Science:

  • Skeletal biology
  • Molecular endocrinology
  • Bone physiology

Background:

  • Wnt signaling is crucial for bone formation, as evidenced by mutations in its co-receptors LRP5 and LRP6.
  • Dickkopf-1 (Dkk1) is a known inhibitor of LRP5/6 activity, suggesting a role in regulating bone metabolism.

Purpose of the Study:

  • To investigate the role of Dkk1 in bone formation.
  • To determine the expression pattern of endogenous Dkk1 in mice.
  • To assess the skeletal consequences of osteoblast-specific Dkk1 overexpression.

Main Methods:

  • Examined endogenous Dkk1 expression in osteoblasts and osteocytes of young mice.
  • Generated transgenic mice with differential Dkk1 overexpression using rat collagen 1A1 promoters (Col1A1 3.6 kb and Col1A1 2.3 kb).
  • Assessed bone phenotypes, osteoblast numbers, serum osteocalcin, and in vitro osteoblast mineralization.

Main Results:

  • Widespread Dkk1 overexpression (Col1A1 3.6 kb) caused osteopenia, limb deformities, and hairlessness.
  • Osteoblast-restricted Dkk1 overexpression (Col1A1 2.3 kb) induced severe osteopenia without other defects.
  • Dkk1 overexpression significantly reduced osteoblast numbers (49%) and serum osteocalcin (45%), and suppressed osteoblast mineralization in vitro.

Conclusions:

  • Dkk1 directly influences bone formation.
  • Osteopenia in Dkk1-overexpressing mice is primarily due to reduced bone formation driven by decreased osteoblast numbers.
  • Dkk1 is a key regulator of osteoblast function and bone mass.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...